Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in chronic hepatitis B with liver dysfunction
IRCT2017010631252N3Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of atorvastatin in hepatitis B (HBV) and Chronic Hepatitis B (CHB), sponsored by Qom University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
hepatitis B (HBV)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on IRCT2017010631252N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017010631252N3.